A strategy to immunize young infants against measles

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN45483324

Enrollment

150

Registered

2005-11-03

Start date

2003-07-02

Completion date

Unknown

Last updated

2021-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Measles Infections and Infestations Measles

Interventions

Edmonston-Zagreb measles vaccine given at 4 and 9 months of age versus vaccine given at 9 months of age

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy children whose parents agree to the trial

Exclusion criteria

Exclusion criteria: Malnourished children or those with a febrile illness

Design outcomes

Primary

Measure	Time frame
Gamma interferon elispot counts after stimulation of peripheral blood mononuclear cells with measles virus at 18 months of age	—

Secondary

Measure	Time frame
Measles haemagglutinin inhibiting antibody at 18 months of age	—

Countries

Gambia

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026